FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Patent news from FiercePharma

News

EU commissioner widens pharma probe

Europe's competition commissioner is casting a wide net in her pharma-market antitrust probe. After questioning some 100 companies--including Pfizer, GlaxoSmithKline, and Read more...
Tags: GlaxoSmithKline   Pfizer   Abbott   Patent   Europe  

GSK accused of monopolizing Wellbutrin

Did GlaxoSmithKline try to monopolize the Wellbutrin market? A lawsuit now certified as class-action says so. The plaintiffs accuse GSK of artificially boosting Wellbutrin prices by fibbing to the Read more...

Drugmakers resist U.K. price goals

Drug companies are standing their ground in price negotiations with the U.K. government. Pharma is offering to cut the U.K.'s drug bill by roughly half the government's goal, The Daily Telegraph Read more...

Wyeth discounts Pristiq for big sales push

Think the latest-and-greatest drug would naturally be the most expensive? Think again. Now that its Pristiq antidepressant is Read more...

Neurontin fails bipolar med review

Review the research on epilepsy meds, and what do you find? Neurontin (gabapentin), is no better than placebo for bipolar disorder, according to the Prescribing for Better Outcomes center at the Read more...
Tags: Neuronin   Pfizer   gabapentin   Patent  

Pfizer might be liable for generic Neurontin

You may pay the fine though you never collected the revenue. That's what a Philadelphia judge told Pfizer and Warner-Lambert last week in a trial over off-label marketing of Neurontin. If the Read more...
Tags: Generics   Pfizer   Patent   FDA  

BBC: Reckitt schemed against generics

Reckitt Benckiser execs bragged in internal documents that they'd blocked generic competition for their Gaviscon stomach med for years--even after the drug went off patent. According to the BBC, The Read more...
Tags: Generics   NHS   Patent  

Bayer loses Yasmin patent fight

Bayer had the Yasmin rug pulled out from under it yesterday. A U.S. court voided the contraceptive's key patent, leading the German conglomerate to revise its 2008 profit expectations Read more...

Teva abstains from Protonix fray

Teva Pharmaceuticals' dilemma: A rival generic drugmaker is ready Read more...
Tags: India   Wyeth   Protonix   Patent  

FDA shoots down Mevacor OTC

It's official: Merck's off-patent statin drug Mevacor can't go over-the-counter. About a month after Read more...
Tags: FDA   Merck   Patent   Approvable letter   OTC   Statins  

Press Releases

PRESS RELEASE: Teva Receives Favorable Court Decision Regarding Generic Famvir Tablets

Teva Receives Favorable Court Decision Regarding Generic Famvir Tablets; Novartis’ Motion for Preliminary Injunction Denied JERUSALEM, Israel--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) Read more...

PRESS RELEASE: Forest Laboratories Announces Federal Appeals Court Upholds Lexapro Patent Decision

Forest Laboratories Announces Federal Appeals Court Upholds Lexapro Patent Decision NEW YORK, Sept. 5 -- Forest Laboratories and H. Lundbeck A/S of Denmark said today that the U.S. Court of Appeals Read more...

Get more Patent coverage at: